Shanghai Rightongene Biotechnology Co., Ltd. (SHA:688217)

SHA:688217 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,500	1,018	1,999	1,965	4,042	-
Market Cap Growth	-24.63%	-49.08%	1.72%	-51.39%	-	-
Enterprise Value	1,291	835	1,790	1,692	3,916	-
Last Close Price	27.18	18.44	35.78	35.19	72.39	-
PE Ratio	-	-	252.00	48.54	85.39	-
Forward PE	108.72	76.83	41.61	-	-	-
PS Ratio	6.44	4.20	7.74	4.63	13.89	-
PB Ratio	1.63	1.11	2.07	2.02	4.51	-
P/TBV Ratio	1.74	1.19	2.30	2.27	5.08	-
P/FCF Ratio	70.12	49.48	-	-	-	-
P/OCF Ratio	25.42	16.97	44.32	26.89	51.84	-
EV/Sales Ratio	5.54	3.45	6.93	3.99	13.46	-
EV/EBITDA Ratio	47.82	40.23	61.41	16.32	65.23	-
EV/EBIT Ratio	-	-	-	23.24	144.85	-
EV/FCF Ratio	60.33	40.60	-	-	-	-
Debt / Equity Ratio	0.01	0.02	0.03	0.01	0.01	0.00
Debt / EBITDA Ratio	0.17	0.93	0.85	0.13	0.15	0.01
Debt / FCF Ratio	0.22	1.09	-	-	-	0.02
Asset Turnover	0.23	0.24	0.24	0.42	0.35	0.42
Inventory Turnover	1.23	1.21	1.23	3.65	2.45	2.56
Quick Ratio	9.08	10.73	10.17	6.17	14.85	8.27
Current Ratio	10.68	12.14	11.97	6.93	16.64	10.37
Return on Equity (ROE)	-2.42%	-2.74%	-0.50%	7.06%	5.14%	6.11%
Return on Assets (ROA)	-1.03%	-1.18%	-0.59%	4.48%	2.04%	3.48%
Return on Capital (ROIC)	-1.09%	-1.23%	-0.64%	4.81%	2.15%	3.75%
Return on Capital Employed (ROCE)	-	-	-	7.30%	3.00%	5.70%
Earnings Yield	-0.86%	-1.55%	0.40%	2.06%	1.17%	-
FCF Yield	1.43%	2.02%	-3.20%	-1.70%	-0.44%	-
Dividend Yield	-	-	0.50%	-	-	-
Payout Ratio	-	-	131.08%	0.03%	0.04%	-
Buyback Yield / Dilution	-5.78%	0.61%	-2.17%	-11.28%	-19.69%	0.12%
Total Shareholder Return	-	0.61%	-1.67%	-11.28%	-19.69%	0.12%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.